Source: International Congress 2018 – Mechanisms of respiratory infection
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Strong (London, United Kingdom), J. Zhu (London, United Kingdom), D. Jackson (London, United Kingdom), J. Dhariwal (London, United Kingdom), M. Trujillo-Torralbo (London, United Kingdom), S. Johnston (London, United Kingdom), M. Edwards (London, United Kingdom). Suppressor of cytokine signalling 1 (SOCS1) and asthma exacerbations. 2647

Member's Comments

No comment yet.

Related content which might interest you: The role of suppressor of cytokine signalling 1 (SOCS1) in virus-induced asthma exacerbations Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab Year: 2016 Interleukin-17 cytokine signalling in patients with asthma Source: Eur Respir J 2014; 44: 1319-1331 Year: 2014 Analysis of cytokine signaling through the STAT6 activation in patients with atopic steroid-free asthma Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy Year: 2007 The expression of IL17RA (the common subunit of IL-17A and IL-25 receptor) on sputum macrophages in asthma patients Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD Year: 2021 Reduced epithelial suppressor of cytokine signalling 1 in severe eosinophilic asthma Source: Eur Respir J 2016; 48: 715-725 Year: 2016 Regulation of NF-kappaB-dependent cytokines during exacerbations of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 824s Year: 2006 Neutrophils and neutrophil chemokine receptor (CXCR1 and 2) gene expression in severe exacerbations of COPD and asthma Source: Eur Respir J 2001; 18: Suppl. 33, 501s Year: 2001 Overexpression of suppressor of cytokine signaling-5 augments eosinophilic inflammation in an asthma model Source: Eur Respir J 2004; 24: Suppl. 48, 348s Year: 2004 Egr-1 regulates muc5ac expression through activator protein-1 (AP-1) in chronic airway inflammation diseases Source: International Congress 2015 – Translational studies in airway cell biology Year: 2015 Analysis of cytokine signaling pathway JAK-STAT through their activation in patients with asthma Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008 Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 551s Year: 2006 Enrichment of the Janus kinase (JAK) activation signature in severe asthma sputum: Correlation with IL-13 expression Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Differential gene expression and cytokine production from neutrophils in asthma phenotypes Source: Eur Respir J 2010; 35: 522-531 Year: 2010 STAT4 activation in smokers and patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: 78-85 Year: 2004 IL-5/IL-13 drive NLRP3 inflammasome-mediated, steroid-resistant AHR in a model of obesity-associated asthma Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019 The roles of Th2 cytokines and their signaling pathways in the pathogenesis of non-eosinophilic asthma enhanced by dsRNA Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs Year: 2006 Cytokine receptors expression in induced sputum in asthma and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 159s Year: 2001 MiR-1165-3p downregulated in Th2 cells inhibits Th2 differentiation in allergic asthma by targeting PPM1A Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease Year: 2019 Decreased PTEN amplifies PI3K signaling and enhances pro-inflammatory cytokine release in COPD Source: International Congress 2016 – Studies in airway cell biology Year: 2016